Furthermore, short-term supplementation of active lactic acid bacteria exhibits effectiveness and safety for improving intestinal mucosal barrier function in patients with IBS by upregulating the tight junction proteins occludin and zonula occludens-1 (ZO-1) [19]. The gene discussed is OCLN; the disease is irritable bowel syndrome.